Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial.
Fonteyne V, Dirix P, Van Praet C, Berghen C, Albersen M, Junius S, Liefhooghe N, Noé L, De Meerleer G, Ost P, Villeirs G, Verbeke S, De Maeseneer D, Rammant E, Verghote F, Elhaseen E, De Man K, Decaestecker K. Fonteyne V, et al. Among authors: noe l. Eur Urol Focus. 2022 Sep;8(5):1238-1245. doi: 10.1016/j.euf.2021.11.004. Epub 2021 Dec 8. Eur Urol Focus. 2022. PMID: 34893458 Free article. Clinical Trial.
A long-term follow-up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis.
Robijns J, Lodewijckx J, Claes M, Lenaerts M, Van Bever L, Claes S, Pannekoeke L, Verboven K, Noé L, Maes A, Bulens P, Mebis J. Robijns J, et al. Among authors: noe l. Lasers Surg Med. 2022 Dec;54(10):1261-1268. doi: 10.1002/lsm.23608. Epub 2022 Oct 2. Lasers Surg Med. 2022. PMID: 36183377
Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial).
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: noe l. Lasers Surg Med. 2018 Feb 10. doi: 10.1002/lsm.22804. Online ahead of print. Lasers Surg Med. 2018. PMID: 29427390
Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).
Robijns J, Lodewijckx J, Puts S, Vanmechelen S, Van Bever L, Claes S, Pannekoeke L, Timmermans A, Noé L, Govers M, Van de Werf E, Maes A, Bulens P, Mebis J. Robijns J, et al. Among authors: noe l. Lasers Surg Med. 2022 Mar;54(3):374-383. doi: 10.1002/lsm.23475. Epub 2021 Sep 4. Lasers Surg Med. 2022. PMID: 34481420 Clinical Trial.
A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J, Van Bever L, Hermans S, Claes M, Lodewijckx J, Lenaerts M, Tuts L, Vandaele E, Vinken E, Noé L, Verboven K, Maes A, Van de Velde AS, Bulens P, Bulens P, Van den Bergh L, Mebis J. Robijns J, et al. Among authors: noe l. Support Care Cancer. 2023 Oct 11;31(12):625. doi: 10.1007/s00520-023-08096-5. Support Care Cancer. 2023. PMID: 37819539 Clinical Trial.
Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: noe l. Radiother Oncol. 2021 Aug;161:255-256. doi: 10.1016/j.radonc.2021.06.009. Epub 2021 Jun 10. Radiother Oncol. 2021. PMID: 34119590 No abstract available.
Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: noe l. Radiother Oncol. 2021 Oct;163:242-243. doi: 10.1016/j.radonc.2021.07.002. Epub 2021 Jul 16. Radiother Oncol. 2021. PMID: 34274395 No abstract available.
Letter to the Editor concerning the article "Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer".
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Broux V, Lodewijckx J, Puts S, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: noe l. World J Surg Oncol. 2019 Mar 23;17(1):57. doi: 10.1186/s12957-019-1603-y. World J Surg Oncol. 2019. PMID: 30904020 Free PMC article.
Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: noe l. Radiother Oncol. 2021 May;158:268-275. doi: 10.1016/j.radonc.2021.03.002. Epub 2021 Mar 10. Radiother Oncol. 2021. PMID: 33711412 Free article. Clinical Trial.
Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Lodewijckx J, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: noe l. Support Care Cancer. 2019 Apr;27(4):1245-1254. doi: 10.1007/s00520-018-4487-4. Epub 2018 Oct 1. Support Care Cancer. 2019. PMID: 30270415 Clinical Trial.
100 results